121.70 0.00 (0.00%)
After hours: 4:00PM EST
|Bid||121.40 x 800|
|Ask||121.76 x 800|
|Day's range||119.27 - 121.92|
|52-week range||65.53 - 148.74|
|Beta (3Y monthly)||1.60|
|PE ratio (TTM)||70.47|
|Earnings date||12 Feb 2020 - 17 Feb 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||143.27|
Zacks.com featured highlights include: Avinger, Alexion Pharmaceuticals, CyberArk Software, Organovo and Qualys
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
CyberArk (CYBR) third-quarter 2019 earnings benefit from increased demand for privileged access security. Moreover, strong demand across energy and pharmaceutical verticals drives revenues.
CyberArk (CYBR) delivered earnings and revenue surprises of 38.30% and 4.94%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
If you own shares in CyberArk Software Ltd. (NASDAQ:CYBR) then it's worth thinking about how it contributes to the...
CyberArk's (CYBR) Q3 earnings might have gained from increasing clientele of its Privileged Account Security offering. However, high expenses are likely to have weighed on margins.
CyberArk (CYBR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Udi Mokady has been the CEO of CyberArk Software Ltd. (NASDAQ:CYBR) since 2005. This analysis aims first to contrast...
As an investor, I look for investments which does not compromise one fundamental factor for another. By this I mean, I...
From Mimecast Limited to Forescout Technologies, Inc., the selloff in cybersecurity stocks has been brutal in recent weeks. But a key technical indicator suggests the group may have hit a bottom, according to All Start Charts. "Within that same theme we're looking at the Cybersecurity subsector finding support at its all-time low relative to the […]
Palo Alto Networks (PANW) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.